Since 2022, four GLP-1 drugs, including those indicated for weight loss, have been on FDA’s drug shortage list due to extraordinarily high patient demand. The shortage has, in turn, resulted in ...

Another US-based pharmaceutical compounding pharmacy has recalled all of its products after it said they could potentially be contaminated with mold. A similar recall was initiated in 2012 by the New ...

If that proposal is finalized, the exclusion would likely limit the mass compounding of those medicines ​unless they appear ...

Discover how compounding pharmacies are transforming healthcare by creating tailor-made medications for patients with unique needs, offering critical alternatives when standard drugs fall short, and ...

– What are the resumes of top management? Are pharmacists leading the company? – Who is available for technical questions and how fast are they answered? – What are the qualifications of the staff and ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in injectables, anesthesia and drug compounding, today announced five new injectable pharmaceutical product ...

With the popularity of GLP-1s skyrocketing, the “P,” which stands for peptides, is having its own moment. Peptides are naturally occurring chains of amino acids that send signals to our bodies to ...

Last week, the US Food and Drug Administration (FDA) announced the end of a years-long shortage of semaglutide injection products — a popular glucagon-like peptide 1 (GLP-1) weight loss and diabetes ...

While Congress debates the high cost of brand-name diabetes and weight loss drugs, Atlanta doctors are selling lower-cost alternatives made by compounding pharmacies. During a Senate committee hearing ...